SCOPUS 정보 검색 플랫폼

Volumn 59, Issue SUPPL. 1, 2000, Pages 31-37

Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies

(8) Kurebayashi, Junichi a,b Sonoo, Hiroshi a,b Inaji, Hideo b Nishimura, Reiki b Iino, Yuichi b Toi, Masakazu b Kobayashi, Shunzo b Saeki, Toshiaki b

a KAWASAKI MEDICAL SCHOOL (Japan)

b Study Group for Cancer Research (Japan)

Author keywords

Breast cancer, recurrence; Endocrine therapy; Predictive factor; Sequence; Survival

Indexed keywords

ANTIESTROGEN; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; GESTAGEN; GONADORELIN AGONIST;

ADULT; AGED; BONE METASTASIS; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; HORMONE RESPONSE; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER; SOFT TISSUE CANCER; TREATMENT OUTCOME;

EID: 0033666898 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000055285 Document Type: Conference Paper

Times cited : (15)

References (15)

1
- 0002426053
- Hormonal therapy and chemotherapy: Treatment of metastatic disease
- Harris JR, Lippman ME, Morrow M, Hellman S (eds): Diseases of the Breast. Philadelphia, Lippincott-Raven
- (1996) , pp. 674-693
- Honig, S.F.¹

2
- 0025730266
- pNR-2/pS2 immunohistochemical staining in breast cancer: Correlation with prognostic factors and endocrine response
- (1991) Br J Cancer , vol.63 , pp. 615-622
- Henry, J.A.¹ Piggott, N.H.² Mallick, U.K.³ Nicholson, S.⁴ Farndon, J.R.⁵ Westley, B.R.⁶ May, F.E.⁷

3
- 0024531977
- Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer
- (1989) Lancet , vol.1 , pp. 182-185
- Nicholson, S.¹ Sainsbury, J.R.² Halcrow, P.³ Chambers, P.⁴ Farndon, J.R.⁵ Harris, A.L.⁶

4
- 0026502860
- Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer
- (1992) Br J Cancer , vol.65 , pp. 118-121
- Wright, C.¹ Nicholson, S.² Angus, B.³ Sainsbury, J.R.⁴ Farndon, J.⁵ Cairns, J.⁶ Harris, A.L.⁷ Horne, C.H.⁸

5
- 0019847618
- Tamoxifen versus aminoglutethimide in advanced breast carcinoma: A randomized cross-over trial
- (1981) Br Med J , vol.283 , pp. 1432-1434
- Smith, I.E.¹ Harris, A.L.² Morgan, M.³ Ford, H.T.⁴ Gazet, J.C.⁵ Harmer, C.L.⁶ White, H.⁷ Parsons, C.A.⁸ Villardo, A.⁹ Walsh, G.¹⁰ McKinna, J.A.¹¹

6
- 0020320287
- Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer
- (1982) Cancer Res , vol.42 , Issue.SUPPL. , pp. 3451-3453
- Harvey, H.A.¹ Lipton, A.² White, D.S.³ Santen, R.J.⁴ Boucher, A.E.⁵ Shafik, A.S.⁶ Dixon, R.J.⁷

7
- 0023904391
- Sequential hormone therapy for advanced breast cancer
- (1988) Semin Oncol , vol.15 , pp. 38-43
- Von Roenn, J.H.¹ Bonomi, P.D.² Gale, M.³ Anderson, K.M.⁴ Wolter, J.M.⁵ Economou, S.G.⁶

8
- 0027492008
- Primary endocrine therapy for advanced breast cancer: To start with tamoxifen or with medroxyprogesterone acetate?
- (1993) Ann Oncol , vol.4 , pp. 735-740
- Castiglione-Gertsch, M.¹ Pampallona, S.² Varini, M.³ Cavalli, F.⁴ Brunner, K.⁵ Senn, H.J.⁶ Goldhirsch, A.⁷ Metzger, U.⁸

9
- 0027953320
- Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen
- (1994) Cancer , vol.73 , pp. 354-361
- Gale, K.E.¹ Andersen, J.W.² Tormey, D.C.³ Mansour, E.G.⁴ Davis, T.E.⁵ Horton, J.⁶ Wolter, J.M.⁷ Smith, T.J.⁸ Cummings, F.J.⁹

10
- 0028145106
- Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: A Piedmont Oncology Association study
- (1994) J Clin Oncol , vol.12 , pp. 1630-1638
- Muss, H.B.¹ Case, L.D.² Atkins, J.N.³ Bearden III, J.D.⁴ Cooper, M.R.⁵ Cruz, J.M.⁶ Jackson D.V., Jr.⁷ O'Rourke, M.A.⁸ Pavy, M.D.⁹ Powell, B.L.¹⁰

11
- 0030787363
- A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1
- (1997) Breast Cancer Res Treat , vol.44 , pp. 211-215
- Sawka, C.A.¹ Pritchard, K.I.² Shelley, W.³ DeBoer, G.⁴ Paterson, A.H.⁵ Meakin, J.W.⁶ Sutherland, D.J.⁷

12
- 0006875251
- Criteria for the evaluation of efficacy of therapies in advanced and recurrent breast cancer patients
- Tokyo, Kanehara
- (1996) General Rules for Clinical and Pathological Recording of Breast Cancer (in Japanese) , pp. 57-68

13
- 0006919853
- Histological classification of breast tumors
- Tokyo, Kanehara
- (1996) General Rules for Clinical and Pathological Recording of Breast Cancer (in Japanese) , pp. 19-56

14
- 0029789811
- Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
- (1996) J Clin Oncol , vol.14 , pp. 2197-2205
- Greenberg, P.A.¹ Hortobagyi, G.N.² Smith, T.L.³ Ziegler, L.D.⁴ Frye, D.K.⁵ Buzdar, A.U.⁶

15
- 84863229253
- Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan
- (1999) Breast Cancer , vol.6 , pp. 344-350
- Sonoo, H.¹ Kurebayashi, J.² Iino, Y.³ Inaji, H.⁴ Watanabe, T.⁵ Toi, M.⁶ Kobayashi, S.⁷ Sato, B.⁸ Yoshimoto, M.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.